Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics EPS Diluted (Quarterly) : -0.4931 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4931 |
| June 30, 2026 | -1.169 |
| March 31, 2026 | -0.4746 |
| December 31, 2025 | -0.4509 |
| Date | Value |
|---|---|
| September 30, 2025 | -0.4211 |
| June 30, 2025 | -0.2816 |
| March 31, 2025 | -0.2452 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 0.0858 |
| Bristol Myers Squibb Co. | 1.053 |
| Harmony Biosciences Holdings, Inc. | 0.8076 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.39M |
| Total Expenses (Quarterly) | 26.39M |
| Enterprise Value | 783.79M |
| Earnings Yield | -12.95% |
| Normalized Earnings Yield | -12.95 |